300142 Walvax Biotechnology
- 10.05
- -0.09-0.89%
Walvax Biotechnology News
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240905
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240903
Watson Biotech: 300142 Watson Biotech Investor Relations Management Information 20240830
Watson Biotech: Special Report on the Deposit and Actual Use of Funds Raised for the First Half of 2024
Watson Biotech: Announcement on the Company\'s Receipt of an Invention Patent Certificate
Watson Biotech: Announcement on subsidiaries applying for comprehensive credit lines from banks
Watson Bio: 2024 Semi-Annual Report Summary
Watson Biotech: Announcement of Board Resolutions
Watson Biotech: Supervisory Board Resolution Announcement
Watson Biotech: Announcement on the 2024 Semi-Annual Credit Impairment Preparation and Asset Impairment Preparation
Watson Bio: 2024 Semi-Annual Report
Watson Biotech: Announcement on holding an online briefing on 2024 semi-annual results
Watson Biotech: 2024 Semi-Annual Report Disclosure Reminder
Watson Biotech: Summary table of non-operating capital expenditure and other related capital transactions for the 2024 semi-year
Watson Biotech: Subsidiary Management System (August 2024)
Walvax Biotechnology: Announcement Regarding the Completion of Business Registration Changes for the Wholly-Owned Subsidiary.
Walvax Biotechnology: Announcement on the completion of share repurchase cancellation and changes in shareholding
Walvax Biotechnology: Announcement Regarding the Election of Vice Chairman of the Board and Changes to Some Senior Management Personnel.
Walvax Biotechnology: Announcement Regarding the Completion of Business Registration Changes for the Wholly-Owned Subsidiary.
Walvax Biotechnology: Announcement of resolutions of the 22nd meeting of the 5th board of directors.
Analysis
Price Target
No Data
